Philadelphia-negative acute promyelocytic leukemia in a patient with chronic myeloid leukemia in complete cytogenetic response after treatment with tyrosine kinase inhibitor

被引：3
作者：
Inokura, Kyoko [1 ]
Onishi, Yasushi [1 ]
Shimosegawa, Kenji [2 ]
Okitsu, Yoko [1 ]
Katsuoka, Yuna [1 ]
Fujiwara, Tohru [1 ]
Fukuhara, Noriko [1 ]
Ishizawa, Kenichi [1 ]
Harigae, Hideo [1 ]
机构：
[1] Tohoku Univ Hosp, Dept Hematol & Rheumatol, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Iwate Prefectural Chubu Hosp, Dept Hematol, Kitakami, Iwate 0248507, Japan
来源：
ANNALS OF HEMATOLOGY | 2012年 / 91卷 / 11期
关键词：
CHRONIC MYELOGENOUS LEUKEMIA; IMATINIB MESYLATE; THERAPY; CRISIS; MALIGNANCIES; CML;
D O I：
10.1007/s00277-012-1477-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1825 / 1826
页数：2
相关论文
共 10 条
  • [1] Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8
    Andersen, MK
    Pedersen-Bjorgaard, J
    Kjeldsen, L
    Dufva, IH
    Brondum-Nielsen, K
    [J]. LEUKEMIA, 2002, 16 (07) : 1390 - 1393
  • [2] Successful management with an effective induction regimen followed by allogeneic hematopoietic stem cell transplantation for promyelocytic blast crisis of chronic myelogenous leukemia
    Cai, Bo
    Yang, Weidong
    Zhao, Yu
    Yuan, Lei
    Wang, Lili
    Gao, Li
    Wang, Nan
    Yu, Li
    Gao, Chunji
    [J]. ANNALS OF HEMATOLOGY, 2012, 91 (04) : 621 - 623
  • [3] Chung HJ, 2008, ANN CLIN LAB SCI, V38, P283
  • [4] Acute lymphoblastic leukemia without the Philadelphia chromosome occurring in chronic myelogenous leukemia with the Philadelphia chromosome
    Huh, HJ
    Huh, JW
    Seong, CM
    Lee, M
    Chung, WS
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2003, 74 (03) : 218 - 220
  • [5] Successful imatinib and arsenic trioxide combination therapy for sudden onset promyelocytic crisis with t(15;17) in chronic myeloid leukemia
    Kashimura, Makoto
    Ohyashiki, Kazuma
    [J]. LEUKEMIA RESEARCH, 2010, 34 (08) : E213 - E214
  • [6] Promyelocytic crisis of chronic myelogenous leukaemia during imatinib mesylate treatment
    Oku, Eijiro
    Imamura, Rie
    Nagata, Shuichiro
    Takata, Yuka
    Seki, Ritsuko
    Otsubo, Korenori
    Hashiguchi, Michitoshi
    Osaki, Koichi
    Yakushiji, Kazuaki
    Yoshimoto, Kohji
    Ogata, Hideaki
    Sata, Michio
    Okamura, Takashi
    [J]. ACTA HAEMATOLOGICA, 2007, 117 (04) : 191 - 196
  • [7] Epidemiological analysis of second primary malignancies in more than 9500 patients treated with imatinib
    Pilot, PR
    Sablinska, K
    Owen, S
    Hatfield, A
    [J]. LEUKEMIA, 2006, 20 (01) : 148 - 148
  • [8] Philadelphia-negative secondary acute myeloid leukaemia during imatinib treatment for chronic phase chronic myeloid leukaemia
    Ross, David M.
    Jackson, Sharon R.
    Browett, Peter J.
    [J]. LEUKEMIA & LYMPHOMA, 2007, 48 (06) : 1231 - 1233
  • [9] Unexpected occurrence of second malignancies in patients treated with interferon followed by imatinib mesylate for chronic myelogenous leukemia
    Roy, L
    Guilhot, J
    Martineau, G
    Larchée, R
    Guilhot, F
    [J]. LEUKEMIA, 2005, 19 (09) : 1689 - 1692
  • [10] Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies
    Verma, Dushyant
    Kantarjian, Hagop
    Strom, Sara S.
    Rios, Mary Beth
    Jabbour, Elias
    Quintas-Cardama, Alfonso
    Verstovsek, Srdan
    Ravandi, Farhad
    O'Brien, Susan
    Cortes, Jorge
    [J]. BLOOD, 2011, 118 (16) : 4353 - 4358
1